Markers of Inflammation and Rapid Coronary Artery Disease Progression in Patients With Stable Angina Pectoris

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Circulation

• Publication date

  2004-09-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.0000142664.18739.92PMID 15381646
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Matrix metalloproteinases and cardiovascular disease.

  2006cited by this paper
• Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes

  2004cited by this paper
• Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery disease.

  2004cited by this paper
• C-reactive protein elevation and disease activity in patients with coronary artery disease.

  2004cited by this paper
• Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.

  2004cited by this paper
• Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia.

  2002cited by this paper
• C-reactive protein and multiple complex coronary artery plaques in patients with primary unstable angina.

  2002cited by this paper
• Elevated C-Reactive Protein Values and Atherosclerosis in Sudden Coronary Death: Association With Different Pathologies

  2002cited by this paper
• Multiple Atherosclerotic Plaque Rupture in Acute Coronary Syndrome: A Three-Vessel Intravascular Ultrasound Study

  2002cited by this paper
• Soluble Intercellular Adhesion Molecule-1, Soluble Vascular Adhesion Molecule-1, and the Development of Symptomatic Peripheral Arterial Disease in Men

  2002cited by this paper
• The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting: The Global Evaluation of New Events and Restenosis After Stent Implantation Study.

  2002cited by this paper
• Increased plasma endothelin levels in angina patients with rapid coronary artery disease progression.

  2001cited by this paper
• Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study.

  2001cited by this paper
• Circulating Matrix Metalloproteinases and Their Inhibitors in Premature Coronary Atherosclerosis

  2001cited by this paper
• C-reactive protein: linking inflammation to cardiovascular complications.

  2001cited by this paper
• Multiple complex coronary plaques in patients with acute myocardial infarction.

  2001cited by this paper
• Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells

  2000cited by this paper
• The New England Journal

  2000cited by this paper
• Multiple complex coronary plaques in patients with acute myocardial infarction.

  2000cited by this paper
• Serum neopterin and complex stenosis morphology in patients with unstable angina.

  2000cited by this paper
• Increased serum neopterin: a marker of coronary artery disease activity in women

  2000cited by this paper
• Matrix Metalloproteinases*

  1999cited by this paper
• Atherosclerotic plaque rupture: pathologic basis of plaque stability and instability

  1999cited by this paper
• Mechanisms of progression in native coronary artery disease: role of healed plaque disruption

  1999cited by this paper
• Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes.

  1998cited by this paper
• Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.

  1998cited by this paper
• Complex stenosis morphology predicts late reocclusion during follow-up after myocardial infarction in patients with patent infarct-related coronary arteries.

  1998cited by this paper
• Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.

  1998cited by this paper
• Serum neopterin in acute coronary syndromes.

  1997cited by this paper
• Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study.

  1997cited by this paper
• Benefit-risk assessment of acne therapies.

  1997cited by this paper
• Serum neopterin in acute coronary syndromes.

  1997cited by this paper
• Rapid angiographic progression of "target" and "nontarget" stenoses in patients awaiting coronary angioplasty.

  1995cited by this paper
• Rapid angiographic progression of coronary artery disease in patients with angina pectoris. The role of complex stenosis morphology.

  1995cited by this paper
• Matrix metalloproteinases and cardiovascular disease.

  1995cited by this paper
• Molecular bases of the acute coronary syndromes.

  1995cited by this paper
• Macrophage Infiltration in Acute Coronary Syndromes: Implications for Plaque Rupture

  1994cited by this paper
• Expression of intercellular adhesion molecule-1 in atherosclerotic plaques.

  1992cited by this paper
• Unstable Angina A Classification

  1989cited by this paper
• Unstable angina. A classification.

  1989cited by this paper
• Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma

  1984cited by this paper
• The Anatomic Evolution of Coronary Artery Disease Demonstrated by Coronary Arteriography in 256 Nonoperated Patients

  1981cited by this paper

• Florescence based analytical assessment of plasma neopterin and its clinical relevance in hypertension

  2026influential citation
• Does Green Brazilian Propolis Extract Improve Functional Capacity in Symptomatic Chronic Coronary Disease?—A Pilot Randomized Trial

  2025cites this paper
• Dietary hempseed and cardiovascular health: nutritional composition, mechanisms and comparison with other seeds

  2025cites this paper
• Identification of biomarkers between coronary artery disease and non-alcoholic steatohepatitis: a combination of bioinformatics and machine learning

  2025cites this paper
• Association between low-density lipoprotein cholesterol and coronary plaque progression in non-dialysis chronic kidney disease: a retrospective cohort study

  2025cites this paper
• Assessment of Inflammatory and Oxidative Stress Biomarkers for Predicting of Patients with Asymptomatic Carotid Artery Stenosis

  2025cites this paper
• Unraveling the rapid progression of non-target lesions: risk factors and the therapeutic potential of PCSK9 inhibitors in post-PCI patients

  2024cites this paper
• Influence of remnant lipoprotein particle cholesterol on non-target lesions progression in patients undergoing percutaneous coronary intervention

  2024cites this paper
• Pre–Coronary Artery Bypass Grafting Computed Tomography–Based Fractional Flow Reserve Predicts Graft Failure: Implications for Planning Invasive Treatment of Coronary Artery Disease

  2024cites this paper
• Pentraxin 3: A promising Therapeutic Target for Cardiovascular Diseases.

  2023cites this paper
• Serum and genetic markers related to rapid clinical progression of coronary artery disease.

  2023cites this paper
• Evaluation of neopterin levels and kynurenine pathway in patients with acute coronary syndrome

  2023cites this paper
• Lifestyle approach and medical therapy of lower extremity peripheral artery disease.

  2023cites this paper
• Influence of LDL-Cholesterol Lowering on Coronary Plaque Progression of Non-Target Lesions in Patients Undergoing Percutaneous Coronary Intervention: Findings from a Retrospective Study

  2023influential citation
• Mental stress, atheroma, myocardial ischaemia and injury: the link is inflammation

  2023cites this paper
• The Effect of PCSK9 Inhibition on the Stabilization of Atherosclerotic Plaque Determined by Biochemical and Diagnostic Imaging Methods

  2023cites this paper
• Role of neopterin as an inflammatory biomarker in congestive heart failure with insights on effect of drug therapies on its level

  2022influential citation
• Impact of PCSK9 Inhibition on Proinflammatory Cytokines and Matrix Metalloproteinases Release in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque

  2022cites this paper
• The impact of uremic toxins on Alzheimer's disease.

  2022cites this paper
• Plasma Concentrations of New Biochemical Markers of Atherosclerosis in Patients with Dyslipidemia—A Pilot Study

  2022cites this paper
• Genetic Polymorphism of Matrix Metalloproteinase-9 and Susceptibility to Myocardial Infarction: A Meta-Analysis

  2022cites this paper
• Synergistic Effects of Inflammation and Atherogenic Dyslipidemia on Subclinical Carotid Atherosclerosis Assessed by Ultrasound in Patients with Familial Hypercholesterolemia and Their Family Members

  2022cites this paper
• Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque

  2022cites this paper
• DMSO_A_315986 2871..2878

  2021cites this paper
• Associations Between Inflammation, Cardiovascular Regenerative Capacity, and Cardiovascular Events: A Cohort Study

  2021cites this paper
• Study of Diagnostic Value of Cyclooxygenase-2 and Matrix Metalloproteinases in Atherosclerosis

  2021cites this paper
• Relationship Between Serum Neopterin Level and Peripheral Arterial Plaque in Patients with Type 2 Diabetes

  2021cites this paper
• The Role of C-reactive Protein in Patient Risk Stratification and Treatment

  2021cites this paper
• miR-100 alleviates the inflammatory damage and apoptosis of H2O2-induced human umbilical vein endothelial cells via inactivation of Notch signaling by targeting MMP9

  2021cites this paper
• Study of Neutrophil-Lymphocyte ratio (NLR) in diabetes mellitus

  2020cites this paper
• The prognostic value of elevated matrix metalloproteinase-9 in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: A two-year prospective study

  2020cites this paper
• The prognostic value of elevated matrix metalloproteinase-9 in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: A two-year prospective study.

  2020cites this paper
• Impact of daily glucose fluctuations on cardiovascular outcomes after percutaneous coronary intervention for patients with stable coronary artery disease undergoing lipid‐lowering therapy

  2020cites this paper
• Increased Serum Malondialdehyde-Modified Low-Density Lipoprotein and Coronary Angiographic Progression After Drug-Eluting Stent Implantation in Patients With Stable Angina.

  2020cites this paper
• Impact of long-term glucose variability on coronary atherosclerosis progression in patients with type 2 diabetes: a 2.3 year follow-up study

  2020cites this paper
• Neopterin derivatives - a novel therapeutic target rather than biomarker for atherosclerosis and related diseases.

  2020cites this paper
• Antioxidant and antihyperlipidemic activity of Costus speciosus against atherogenic diet-induced hyperlipidemia in rabbits.

  2019cites this paper
• herramientas en la estratificación del riesgo cardiovascular

  2019cites this paper
• Impact of the Temporal Distribution of Coronary Artery Disease Progression on Subsequent Consequences in Patients with Acute Coronary Syndrome.

  2019cites this paper
• [Markers of Vascular Wall Fibrosis Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Ischemic Heart Disease with and without Concomitant Type-2 Diabetes Mellitus].

  2019cites this paper
• CORRELATION BETWEEN SERUM HSCRP AND CORONARY ARTERY DISEASE SEVERITY IN PATIENTS WITH ACUTE STEMI

  2018cites this paper
• Utility of myeloperoxidase in the differential diagnosis of acute coronary syndrome.

  2018cites this paper
• Physical Inactivity is Related to Unheralded Myocardial Infarction More Than Uncomplicated Stable Angina

  2018cites this paper
• Ultra-rapid progression of coronary artery disease or undiagnosed unstable plaque? A brief review from a case report.

  2018cites this paper
• Ultra-rapid progression of coronary artery disease or undiagnosed unstable plaque? A brief review from a case report.

  2018cites this paper
• Neopterin and Cardiovascular Events Following Coronary Stent Implantation in Patients with Stable Angina Pectoris

  2018cites this paper
• Neopterin for prediction of in‐hospital atrial fibrillation – the ‘forgotten biomarker’ strikes again

  2018cites this paper
• The -174 G>C Interleukin-6 Gene Polymorphism is Associated with Angiographic Progression of Coronary Artery Disease over a 4-Year Period.

  2017cites this paper
• Role of Neopterin in Cardiovascular Medicine

  2017cites this paper
• Sex Differences in the Risk of Developing Acute Coronary Syndrome in Patients With Sleep Disorders: A Population-Based Cohort Study

  2017cites this paper
• Impact of renal function on the underlying pathophysiology of coronary plaque composition in patients with type 2 diabetes mellitus

  2017cites this paper
• ST-segment category at acute presentation is associated with the time course of coronary artery disease progression in patients with acute coronary syndromes

  2017influential citation
• Serum Amyloid A Induces a Vascular Smooth Muscle Cell Phenotype Switch through the p38 MAPK Signaling Pathway

  2017cites this paper
• Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis

  2017influential citation
• Severity of coronary atherosclerosis in patients with COPD

  2017cites this paper
• Potential Biomarkers for Depression Associated with Coronary Artery Disease: A Critical Review.

  2016cites this paper
• Stromelysin-1 Gene Promoter 5A/6A Polymorphism and Plasma C-Reactive Protein in Patients with Coronary Artery Disease and Myocardial Infarction

  2016cites this paper
• Elevated Type II Secretory Phospholipase A2 Increases the Risk of Early Atherosclerosis in Patients with Newly Diagnosed Metabolic Syndrome

  2016cites this paper
• Involvement of Serum Matrix Metalloproteinase-9 in the Pathogenesis of Acute Myocardial Infarction

  2016cites this paper
• Reactive Oxygen Species, Antioxidants, Inflammation, and Cardiovascular Disease

  2016cites this paper
• nflammatory Markers and the Metabolic Syndrome nsights From Therapeutic Interventions

  2016cites this paper
• Homocysteine is associated with the progression of non-culprit coronary lesions in elderly acute coronary syndrome patients after percutaneous coronary intervention

  2016cites this paper
• Leukocyte-derived matrix metalloproteinase-9 in patients with coronary artery disease : Associations with psychological stress and glucocorticoid sensitivity

  2015cites this paper
• Neutrophil Lymphocyte Ratio as a predictor of systemic inflammation - A cross-sectional study in a pre-admission setting.

  2015cites this paper
• Potential use of sFlt-1 and pterin to predict the clinical outcome of cardiovascular disease.

  2015cites this paper
• The accuracy of fibrinogen and hs-crp as a biomarker in acute coronary syndrome (ACS)

  2015cites this paper
• Rapid Progression of Coronary Atherosclerosis: A Review

  2015cites this paper
• Acetylcholine-induced coronary spasm in patients with unobstructed coronary arteries is associated with elevated concentrations of soluble CD40 ligand and high-sensitivity C-reactive protein

  2015cites this paper
• Value of pentraxin-3 and galectin-3 in acute coronary syndrome: a short-term prospective cohort study

  2015cites this paper
• Non-culprit coronary lesions in young patients have higher rates of atherosclerotic progression

  2015cites this paper
• Combination of Fibrinogen and High-sensitivity C-reactive Protein Measurements is Potential in Identification of Acute Coronary Syndrome

  2015cites this paper
• Glycemic Variability Predicts Rapid Progression of Non-Culprit Lesions in Patients With Acute Coronary Syndrome.

  2015cites this paper
• Evaluation of neopterin as a prognostic factor in patients with beta-thalassemia, in comparison with cytokines and immunoglobulins

  2015cites this paper
• Glycemic Variability on Continuous Glucose Monitoring System Predicts Rapid Progression of Non-Culprit Lesions in Patients With Acute Coronary Syndrome.

  2015cites this paper
• Atherosclerotic Plaque Morphology Indicates Clinical Symptoms of Plaque Progression

  2014cites this paper
• Immune Activation and Inflammation in Patients with Cardiovascular Disease Are Associated with Higher Phenylalanine to Tyrosine Ratios: The Ludwigshafen Risk and Cardiovascular Health Study

  2014cites this paper
• THE PROSPECTS OF STUDYING THE FEATURES OF VEGETATIVE REGULATION OF BLOOD CIRCULATION SYSTEM ACTIVITY IN THE PATIENTS WITH RHEUMATOID ARTHRITIS BY MEANS OF LASER DOPPLER FLOWMETRY

  2014cites this paper
• ST elevation acute myocardial infarction accelerates non-culprit coronary lesion atherosclerosis

  2014cites this paper
• Modest correlation between serum neopterin levels and Gensini scores in a cohort of patients undergoing coronary angiography

  2014cites this paper
• Residual platelet reactivity in atherosclerosis and its impact on patient outcomes

  2014cites this paper
• Effect of Green Tea Extract and Epigallocatechin-3-Gallate Potency on Lipid Profile and Coronary Artery Morphology of Dyslipidemic Rats

  2014influential citation
• Usefulness of elevated urine neopterin levels in assessing cardiac dysfunction and exercise ventilation inefficiency in patients with chronic systolic heart failure.

  2014cites this paper
• Relation of kynurenine/tryptophan with immune and inflammatory markers in coronary artery disease.

  2014cites this paper
• Positron emission tomography imaging for vascular inflammation evaluation in elderly subjects with different risk factors for cardiovascular diseases.

  2014cites this paper
• The Platelet-Lymphocyte Ratio Predict the Risk of Amputation in Critical Limb Ischemia

  2014cites this paper
• Efficiency of Protease-Activatable Virus Nanonodes Tuned Through Incorporation of Wild-Type Capsid Subunits

  2014cites this paper
• High Sensitivity C-reactive Protein and Cardiovascular Risk Prediction

  2014cites this paper
• Overexpression of MMP-9 and Its Inhibitors in Blood Mononuclear Cells after Myocardial Infarction - Is It Associated with Depressive Symptomatology?

  2014cites this paper
• Preoperative Neutrophil–Lymphocyte Ratio and Saphenous Vein Graft Patency After Coronary Artery Bypass Grafting

  2014cites this paper
• Efficiency of Protease-Activatable Virus Nanonodes Tuned Through Incorporation of Wild-Type Capsid Subunits

  2014cites this paper
• Antioxidants, inflammation and cardiovascular disease.

  2014cites this paper
• Neutrophil–Lymphocyte Ratio and the Platelet–Lymphocyte Ratio Predict the Limb Survival in Critical Limb Ischemia

  2014cites this paper
• Neopterin and kynurenine-tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study.

  2013cites this paper
• Neopterin levels are independently associated with cardiac remodeling in patients with chronic heart failure.

  2013cites this paper
• High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction.

  2013cites this paper
• Pathophysiological roles and clinical importance of biomarkers in acute coronary syndrome.

  2013cites this paper
• What's up with neopterin in cardiovascular pathophysiology?

  2013cites this paper
• Markers of inducible myocardial ischemia in the systemic circulation

  2013cites this paper
• Usefulness of plasma matrix metalloproteinase-9 level in predicting future coronary revascularization in patients after acute myocardial infarction

  2013cites this paper
• Estimation of serum neopterin in patients with acute coronary syndrome

  2013cites this paper